Scott Koenig

Medicine · Health Sciences

64h-index17.9kcitations210works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(76), Immunotherapy and Immune Responses(38), Immune Cell Function and Interaction(36), HIV Research and Treatment(34), CAR-T cell therapy research(33)

Publications210 total

Immunology of AIDS and HIV Infection
2024
A multiwavelength overview of the giant spiral UGC 2885
arXiv (Cornell University)·2024Open Access
Data from Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
2023Open Access
Data from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Data from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Tables S1-S5; Figures S1-S5 from Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
2023Open Access
Video D from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Video B from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Supplementary Figure from Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
2023Open Access
Video D from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Data from Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
2023Open Access
Video E from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Video C from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Supplementary Materials and Methods from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Tables S1-S5; Figures S1-S5 from Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
2023Open Access
Video A from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Supplementary Data from Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
2023Open Access
Supplementary Data from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Video A from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
Supplementary Data from Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Syd Johnson(15), Ezio Bonvini(12), Sergey Gorlatov(8), Paul A. Moore(8), Ling Huang(7), Anthony S. Fauci(6), Solomon Langermann(6), Valentina Ciccarone(6), Robert M. Woods(5), Susan Palaszynski(5), Jeffrey L. Nordstrom(5), Steve Burke(5), Yinhua Yang(5), Hua Li(5), Howard E. Gendelman(4), Steven Jacobson(4), Jeanne E. Burlein(4), Yambasu A. Brewah(4), Giuseppe Pantaleo(4), C. Kendall Stover(4)